Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 204 | 239 | 245 | 63 |
| Receivables | 25 | 0 | 0 | 0 |
| TOTAL | $231 | $250 | $256 | $83 |
| Non-Current Assets | ||||
| TOTAL | $0 | $0 | $0 | $0 |
| Total Assets | $231 | $250 | $256 | $83 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 12 | N/A | N/A | N/A |
| Accrued Expenses | 9 | N/A | N/A | N/A |
| TOTAL | $21 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $0 | $N/A | $N/A | $N/A |
| Total Liabilities | $21 | $0 | $0 | $0 |
| Shareholders' Equity | ||||
| Common Shares | 294 | 350 | 350 | 100 |
| Retained earnings | -185 | -100 | -94 | -17 |
| Other shareholders' equity | 101 | 0 | 0 | 0 |
| TOTAL | $211 | $250 | $256 | $83 |
| Total Liabilities And Equity | $231 | $250 | $256 | $83 |